Posts by Cheikh Kane, Ph.D.
Cheikh Kane, PhD is currently the VP BioPharma Sciences at KCAS Bio where his teams are focused on bioanalytical LBA (PK, ADA and BM), Cell Based NAB (Neutralizing antibody assays) and Molecular to support drug development programs for biologics. Dr. Kane has more than two decades of experience in the bioanalytical and biomarker fields and related strategies spanning from Biopharmaceutical/Biotechnology industry to the CRO business. At KCAS Bio he leads strategic and technical initiatives that drive innovation in bioanalytical, biomarker and molecular sciences and expands the company’s capabilities.
Posters & Papers
Read article Automating Selection for Incurred Sample Reanalysis: A Meta-Analytical-Based Algorithm for Error Reduction
Please download this poster, “Automating Selection for Incurred Sample Reanalysis: A Meta-Analytical-Based Algorithm for Error Reduction”